GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Trade (domestic/foreign) TRD

International trade and protection of intellectual property; compulsory licensing and other IP issues in multiple countries.

Contacted: Natl Institutes of Health (NIH); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); SENATE; Centers For Disease Control & Prevention (CDC); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Indian/Native American Affairs IND

Education related to Hepatitis C and HIV in American Indian population.

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); State, Dept of (DOS); U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); SENATE

Taxation/Internal Revenue Code TAX

Implementation of the Tax Cuts and Jobs Act of 2017 (P.L. 115-97)

Contacted: Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); SENATE; Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); State, Dept of (DOS)

Copyright/Patent/Trademark CPT

Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding.

Contacted: U.S. Trade Representative (USTR); State, Dept of (DOS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); SENATE

Veterans VET

Education related to Hepatitis C and HIV. FY18/19 Military Construction VA Appropriations bill.

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Commerce, Dept of (DOC); State, Dept of (DOS); SENATE; Centers For Disease Control & Prevention (CDC)

Health Issues HCR

Initiatives relating to the Administration's "Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs"; Ryan White Care Act reauthorization; PEPFAR reauthorization; HIV/AIDS research, testing and treatment. HCV screening and linkage to care programs; coverage and reimbursement policy for HCV, HIV and oncology portfolio. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. Support for H.R. 5353/S.2579 - Eliminating Opioid Related Infectious Diseases Act of 2018. FDA safety requirements. Support for H.R. 6 Sec. 7141 - Support for Patients and Communities Act.

Contacted: State, Dept of (DOS); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2579 (115th), H.R. 5353 (115th), H.R. 6 (115th)

Medicare/Medicaid MMM

Initiatives relating to the Administration's "Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs". HCV testing, screening and linkage to care programs. Federal program coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products. Medicaid duplicate discounts.

Contacted: SENATE; State, Dept of (DOS); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

Initiatives relating to the Administration's "Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs". Funding for HCV, HIV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program.

Contacted: Natl Institutes of Health (NIH); State, Dept of (DOS); Centers For Disease Control & Prevention (CDC); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS)